HomeInsightsResults

Kilitch Drugs (india) Ltd Quarterly Result

Kilitch Drugs (india) Ltd Quarterly Result

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

1.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Kilitch Drugs (India) Ltd

NSE: KILITCH

Net Profit

₹ 8.61

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Kilitch Drugs (India) Ltd for the Sep '24 is ₹ 52.64 crore as compare to the Jun '24 revenue of ₹ 36.03 crore. This represent the growth of 46.10047%.
  • The ebitda of Kilitch Drugs (India) Ltd for the Sep '24 is ₹ 11.26 crore as compare to the Jun '24 ebitda of ₹ 4.23 crore. This represent the growth of 166.19385%.
  • The net profit of Kilitch Drugs (India) Ltd for the Sep '24 is ₹ 8.61 crore as compare to the Jun '24 net profit of ₹ 0.11 crore. This represent the growth of 7727%.

Results Analysis

Market Price of Kilitch Drugs (India) Ltd

1M

1Y

3Y

5Y

Monitoring Kilitch Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024309.05
21 Nov 2024308.45
19 Nov 2024311.05
18 Nov 2024315.25
14 Nov 2024332.95
13 Nov 2024328.6
12 Nov 2024301.35
11 Nov 2024301
08 Nov 2024303.55
07 Nov 2024310

Historical Revenue of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Kilitch Drugs (India) Ltd News Hub

News

Kilitch Drugs (India) announces board meeting date

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 12 N...

Read more

05 Nov 202413:41

News

Kilitch Drugs (India) to convene AGM

Kilitch Drugs (India) announced that the 32th Annual General Meeting (AGM) of the company ...

Read more

31 Aug 202415:38

News

Kilitch Drugs (India) to conduct board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 Au...

Read more

02 Aug 202417:27

News

Kilitch Drugs (India) to declare Quarterly Result

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 27 M...

Read more

20 May 202419:21

News

Kilitch Drugs (India) to conduct board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 Fe...

Read more

01 Feb 202419:34

News

Kilitch Drugs (India) to declare Quarterly Result

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

03 Nov 202314:34

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Kilitch Drugs India Ltd Quarterly Result

What is the EPS of Kilitch Drugs (India) Ltd stock?

The Earnings Per Share (EPS) of Kilitch Drugs (India) Ltd is 10.24. An EPS is the amount of net income attributed to each share of a common stock.

How is Kilitch Drugs (India) Ltd EPS calculated?

The EPS of Kilitch Drugs (India) Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Kilitch Drugs (India) Ltd report its EPS?

Kilitch Drugs (India) Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Kilitch Drugs (India) Ltd EPS?

Factors that influence the EPS of Kilitch Drugs (India) Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Kilitch Drugs (India) Ltd EPS growth indicate future performance?

Yes, consistent growth in Kilitch Drugs (India) Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*